GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 135 filers reported holding GENOMIC HEALTH INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $248,000 | -94.9% | 3,664 | -95.7% | 0.01% | -93.6% |
| Q2 2019 | $4,907,000 | -9.3% | 84,349 | +9.2% | 0.14% | -37.5% |
| Q1 2019 | $5,413,000 | +67.1% | 77,276 | +53.7% | 0.22% | +250.0% |
| Q4 2018 | $3,239,000 | +16.7% | 50,285 | +27.2% | 0.06% | -8.6% |
| Q3 2018 | $2,775,000 | +139.0% | 39,523 | +71.5% | 0.07% | +75.0% |
| Q2 2018 | $1,161,000 | +272.1% | 23,040 | +131.0% | 0.04% | +300.0% |
| Q1 2018 | $312,000 | +41.8% | 9,972 | +31.2% | 0.01% | +100.0% |
| Q3 2016 | $220,000 | -28.1% | 7,600 | -35.6% | 0.01% | -16.7% |
| Q2 2016 | $306,000 | -30.8% | 11,800 | -21.9% | 0.01% | -72.7% |
| Q4 2013 | $442,000 | – | 15,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |